WHO ICTRP trial

Hydros and Hydros-TA Joint Therapy for Pain Associated with Knee OA; A…

NL-OMON40374 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON40374
Public title Hydros and Hydros-TA Joint Therapy for Pain Associated with Knee OA; A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated with Osteoarthritis in the Knee
Scientific title Hydros and Hydros-TA Joint Therapy for Pain Associated with Knee OA; A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated with Osteoarthritis in the Knee - COR 1.1
Primary sponsor Carbylan Therapeutics, Inc
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Countries New Zealand
Conditions Joint Degeneration Osteoarthritis;10023213;Joint Degeneration;Osteoarthritis
Interventions Subjects will be treated with one 6mL intra-articular injection with either Hydros, Hydros-TA or Triamcinolone acetonide (10mg) Hydros is a 6mL intra-articular injectable comprised of a bioresorbable hyaluronan-based hydrogel suspended in a…
Registration date Jan 9, 2015
Target size 210
Secondary IDs Het NCT nummer is aangevraagd en zal worden aangeleverd zodra beschikbaar;NL45893.072.13
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations